The growth of the global Hemostasis Analyzer Market is largely driven
by the increasing prevalence of cardiovascular diseases and blood
disorders, technological advancements in coagulation analyzers, and the
rising geriatric population. Emerging economies and growing number of
reagent rental agreements are expected to offer growth opportunities to
market players in the coming years.
According to market research report the global Coagulation Analyzer Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392
Optical technology segment accounted for the largest share of the Coagulation Analyzer Market, by technology, in 2019
The
coagulation analyzers available in the market are based on three major
technologies—optical technology, mechanical technology, and
electrochemical technology. However, apart from these technologies,
coagulation analyzers can also be based on other technologies, such as
nephelometric, immunogenic, chromogenic, advanced biosensor, and
thromboelastometry technologies. The most widely used technology in the
Hemostasis Analyzer Market is the optical technology. This segment
accounted for the largest share of the market in 2019.
Clinical laboratories dominated the Coagulation Analyzer Market in 2019
On
the basis of end user, the Hemostasis Analyzer Market is segmented into
clinical laboratories, hospitals, and other end users. In 2019, the
clinical laboratories segment accounted for the largest share of the
market.
Clinical laboratory analyzers dominated the Coagulation Analyzer Market in 2019
Based
on product, the Hemostasis Analyzer Market is segmented into clinical
laboratory analyzers and point-of-care testing analyzers. In 2019, the
clinical laboratory analyzers segment accounted for a larger share of
the market. The large share of this segment can be attributed to factors
such as the growing prevalence of blood disorders and increasing
development of automated coagulation systems with faster turnaround
times, compact size, and expanded capabilities.
North America is the largest regional market for coagulation analyzers
North
America (comprising the US and Canada) accounted for the largest share
of the global Coagulation Analyzer Market in 2019, followed by Europe.
Factors such as the increasing prevalence of lifestyle diseases and the
rising incidence of blood disorders are stimulating the growth of the
market in North America.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197226392
Siemens
Healthineers (Germany), Thermo Fisher Scientific (US), Roche
Diagnostics (Switzerland), Alere, Inc. (US), Sysmex Corporation (Japan),
Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena
Laboratories (US), and Horiba Medical (Japan) are some of the key
players operating in this Coagulation Analyzer Market.